These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31960098)

  • 1. Direct prospective comparison of
    Ceccarini J; Bourgeois S; Van Weehaeghe D; Goffin K; Vandenberghe R; Vandenbulcke M; Sunaert S; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2142-2154. PubMed ID: 31960098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET.
    Anazodo UC; Finger E; Kwan BYM; Pavlosky W; Warrington JC; Günther M; Prato FS; Thiessen JD; St Lawrence KS
    Neuroimage Clin; 2018; 17():405-414. PubMed ID: 29159053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
    Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA
    Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
    Fällmar D; Haller S; Lilja J; Danfors T; Kilander L; Tolboom N; Egger K; Kellner E; Croon PM; Verfaillie SCJ; van Berckel BNM; Ossenkoppele R; Barkhof F; Larsson EM
    Eur Radiol; 2017 Oct; 27(10):4237-4246. PubMed ID: 28374078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol.
    Vanderlinden G; Carron C; Vandenberghe R; Vandenbulcke M; Van Laere K
    BMC Med Imaging; 2024 Feb; 24(1):41. PubMed ID: 38347458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling.
    Boscolo Galazzo I; Mattoli MV; Pizzini FB; De Vita E; Barnes A; Duncan JS; Jäger HR; Golay X; Bomanji JB; Koepp M; Groves AM; Fraioli F
    Neuroimage Clin; 2016; 11():648-657. PubMed ID: 27222796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis.
    Haidar H; Majzoub RE; Hajeer S; Abbas LA
    BMC Neurol; 2023 Oct; 23(1):385. PubMed ID: 37875879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
    Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
    Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
    Verfaillie SC; Adriaanse SM; Binnewijzend MA; Benedictus MR; Ossenkoppele R; Wattjes MP; Pijnenburg YA; van der Flier WM; Lammertsma AA; Kuijer JP; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
    Eur Radiol; 2015 Oct; 25(10):3050-9. PubMed ID: 25899416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
    Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial spin labeling versus
    Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
    Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative agreement and diagnostic performance of arterial spin labelling MRI and FDG PET-CT in suspected early-stage dementia: Comparison of arterial spin labelling MRI and FDG PET-CT in suspected dementia.
    Weyts K; Vernooij M; Steketee R; Valkema R; Smits M
    Clin Imaging; 2017; 45():1-7. PubMed ID: 28551486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
    O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
    J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders.
    Minoshima S; Mosci K; Cross D; Thientunyakit T
    Semin Nucl Med; 2021 May; 51(3):230-240. PubMed ID: 33546814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India.
    Mukku SSR; Sivakumar PT; Nagaraj C; Mangalore S; Harbishettar V; Varghese M
    Asian J Psychiatr; 2019 Aug; 44():99-105. PubMed ID: 31336358
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Minoshima S; Cross D; Thientunyakit T; Foster NL; Drzezga A
    J Nucl Med; 2022 Jun; 63(Suppl 1):2S-12S. PubMed ID: 35649653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of ASL-MRI and FDG-PET in Frontotemporal Dementia: A Systematic Review and Meta-Analysis.
    Dagher R; Arjmand P; Ozkara BB; Radmard M; Gad M; Sheikhy A; Wintermark M; Yedavalli V; Sair HI; Luna LP
    AJNR Am J Neuroradiol; 2024 Aug; ():. PubMed ID: 39134374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between simultaneously acquired arterial spin labeling and
    Wang YH; An Y; Fan XT; Lu J; Ren LK; Wei PH; Cui BX; Du JL; Lu C; Wang D; Zhang HQ; Shan YZ; Zhao GG
    Neuroimage Clin; 2018; 19():824-830. PubMed ID: 30013926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.